The board of directors of Shanghai Pharmaceuticals Holding Co. Ltd. announced that the principal place of business of the Company in Hong Kong has been changed to 5/F, Manulife Place, 348 Kwun Tong Road, Kowloon, Hong Kong with effect from 20 February 2024.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
18.61 CNY | -1.27% | +3.27% | +11.24% |
May. 14 | Shanghai Pharmaceuticals Unit Gets Green Light to Market Cancer Drug | MT |
May. 14 | Shanghai Pharmaceuticals Gets Regulatory Nod to Trial Tumor Drug | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+11.24% | 8.64B | |
+19.13% | 71.69B | |
-3.66% | 23.65B | |
+9.05% | 9.01B | |
-18.91% | 8.15B | |
+15.87% | 5.33B | |
+17.83% | 4.35B | |
-2.11% | 4.1B | |
-2.41% | 3.94B | |
+27.53% | 3.81B |
- Stock Market
- Equities
- 601607 Stock
- News Shanghai Pharmaceuticals Holding Co., Ltd
- Shanghai Pharmaceuticals Holding Co., Ltd Announces Change of Principal Place of Business in Hong Kong